These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2437788)

  • 1. Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors.
    Podrid PJ; Lampert S; Graboys TB; Blatt CM; Lown B
    Am J Cardiol; 1987 Apr; 59(11):38E-44E. PubMed ID: 2437788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proarrhythmic responses during electrophysiologic testing.
    Horowitz LN; Greenspan AM; Rae AP; Kay HR; Spielman SR
    Am J Cardiol; 1987 Apr; 59(11):45E-48E. PubMed ID: 3578040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of arrhythmia worsening by antiarrhythmic drugs.
    Slater W; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1988 Feb; 61(4):349-53. PubMed ID: 3124591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing.
    Poser RF; Podrid PJ; Lombardi F; Lown B
    Am Heart J; 1985 Jul; 110(1 Pt 1):9-16. PubMed ID: 4013993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggravation of arrhythmia: a complication of antiarrhythmic drug therapy.
    Podrid PJ
    Eur Heart J; 1989 Sep; 10 Suppl E():66-72. PubMed ID: 2680505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can antiarrhythmic drugs cause arrhythmia?
    Podrid PJ
    J Clin Pharmacol; 1984 Jul; 24(7):313-9. PubMed ID: 6480877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.
    Velebit V; Podrid P; Lown B; Cohen BH; Graboys TB
    Circulation; 1982 May; 65(5):886-94. PubMed ID: 6176355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggravation of arrhythmia: a complication of antiarrhythmic drugs.
    Podrid PJ
    J Cardiovasc Electrophysiol; 1993 Jun; 4(3):311-9. PubMed ID: 8269302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing.
    Rae AP; Kay HR; Horowitz LN; Spielman SR; Greenspan AM
    J Am Coll Cardiol; 1988 Jul; 12(1):131-9. PubMed ID: 3379198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
    Au PK; Bhandari AK; Bream R; Schreck D; Siddiqi R; Rahimtoola SH
    J Am Coll Cardiol; 1987 Feb; 9(2):389-97. PubMed ID: 2433319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of experimental and clinical methods on the effectiveness and side effect profile of anti-arrhythmia agents].
    Kuck KH
    Z Kardiol; 1992; 81 Suppl 4():151-5. PubMed ID: 1283932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation.
    Stanton MS; Prystowsky EN; Fineberg NS; Miles WM; Zipes DP; Heger JJ
    J Am Coll Cardiol; 1989 Jul; 14(1):209-15; discussion 216-7. PubMed ID: 2738263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proarrhythmic effects of antiarrhythmic drugs.
    Zipes DP
    Am J Cardiol; 1987 Apr; 59(11):26E-31E. PubMed ID: 2437787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous sustained ventricular tachyarrhythmias during treatment with type IA antiarrhythmic agents.
    Kudenchuk PJ; Kron J; Walance C; McAnulty JH
    Am J Cardiol; 1990 Feb; 65(7):446-52. PubMed ID: 2305683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive evaluation of indecainide for serious ventricular tachyarrhythmia.
    Podrid PJ; Hohnloser S; Lown B
    Am J Cardiol; 1988 Apr; 61(10):764-9. PubMed ID: 2451415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio.
    Pratt CM; Eaton T; Francis M; Woolbert S; Mahmarian J; Roberts R; Young JB
    Am Heart J; 1989 Sep; 118(3):433-40. PubMed ID: 2476016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol.
    Myerburg RJ; Kessler KM; Cox MM; Huikuri H; Terracall E; Interian A; Fernandez P; Castellanos A
    Circulation; 1989 Dec; 80(6):1571-9. PubMed ID: 2480856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proarrhythmia, a serious complication of antiarrhythmic drugs.
    Podrid PJ
    Curr Cardiol Rep; 1999 Nov; 1(4):289-96. PubMed ID: 10980856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmias.
    Hession MJ; Lampert S; Podrid PJ; Lown B
    Am J Cardiol; 1987 Oct; 60(11):59F-66F. PubMed ID: 3310587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of nonsustained ventricular tachycardia as a guide to antiarrhythmic drug therapy in patients with malignant ventricular arrhythmia.
    Podrid PJ; Schoeneberger A; Lown B; Lampert S; Matos J; Porterfield J; Raeder E; Corrigan E
    Am Heart J; 1983 Feb; 105(2):181-8. PubMed ID: 6823797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.